Advertisement
Advertisement

CLRB

CLRB logo

Cellectar Biosciences INC NEW

3.27
USD
Sponsored
-0.04
-1.36%
Jan 29, 15:59 UTC -5
Closed
exchange

After-Market

3.18

-0.08
-2.48%

CLRB Earnings Reports

Positive Surprise Ratio

CLRB beat 19 of 38 last estimates.

50%

Next Report

Date of Next Report
Mar 11, 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$2.06
Implied change from Q3 25 (Revenue/ EPS)
--
/
+46.10%
Implied change from Q4 24 (Revenue/ EPS)
--
/
+14.44%

Cellectar Biosciences INC NEW earnings per share and revenue

On Nov 13, 2025, CLRB reported earnings of -1.41 USD per share (EPS) for Q3 25, beating the estimate of -2.57 USD, resulting in a 45.31% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -18.00% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 6 analysts forecast an EPS of -2.06 USD, with revenue projected to reach -- USD, implying an increase of 46.10% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Abbott Laboratories
Report Date
Jan 22, 2026 For Q4 25
Estimate
$1.51
Actual
$1.50
Surprise
-0.75%
logo
Stryker Corporation
Report Date
Jan 29, 2026 For Q4 25
Estimate
$4.43
Actual
$4.47
Surprise
+0.69%
logo
ResMed Inc.
Report Date
Jan 29, 2026 For Q2 26
Estimate
$2.75
Actual
$2.81
Surprise
+2.15%
FAQ
For Q3 2025, Cellectar Biosciences INC NEW reported EPS of -$1.41, beating estimates by 45.31%, and revenue of $0.00, 0% as expectations.
The stock price moved down -18%, changed from $3.50 before the earnings release to $2.87 the day after.
The next earning report is scheduled for Mar 11, 2026.
Based on 6 analysts, Cellectar Biosciences INC NEW is expected to report EPS of -$2.06 and revenue of -- for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement